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Antimicrobial resistance (AMR) and healthcare-associated infections (HCAIs) remain a critical global 31 challenge [1] . While a standard template for National Action Plans for AMR has been suggested, 32 countries have adopted different interventions to address AMR and HCAIs. A better understanding of 33 what has been attempted at the national level can offer improved contextualisation for the often 34 challenging implementation of large-scale interventions such as National Action Plans. By comparing 35 international responses across different countries, a look at the wider policy setting can help 36 transfer of learning. Global transfer of learning has influenced UK initiatives in the past (e.g. primary 37 care organisational development [2] ) but for infection prevention and control (IPC), England has 38 deviated from its European neighbours in policy approach and particularly the amount of 39 information available in the public domain [3] . International collaboration and cross-border learning 40 from innovative models tackling AMR are encouraged by the UK Department of Health (DH) [4] and 41 Japan Ministry of Health Labour and Welfare (MHLW) [5] . High-income countries, such as Japan and 42 UK, face a further challenge arising from ageing populations, which require careful consideration of 43 sustainable approaches. 44
The AMR National Action Plans in both countries cover similar overarching themes. The Japanese 45 government formulated its plan in April 2016, aiming to cut total antibiotic usage by 33% of the 46 current level by 2020 [5] . However, the UK, in its In Japan, since 1999 MRSA infections have been the subject of sentinel surveillance with 500 70 designated hospitals required to report their monthly number of patients with MRSA infection [13] . 71
This covers approximately 6% of 8000 hospitals in Japan. In 2000, The Japan Nosocomial Infections 72 Surveillance (JANIS), organised by the MHLW, was launched to collect data on multidrug-resistant 73 organism (MDRO) nosocomial infections such as MRSA on a voluntary basis. JANIS member hospitals 74 are required to submit surveillance data monthly. The JANIS system provides anonymous 'Open 75
Reports' for the public (quarterly & annually) and 'Feedback Reports' for member hospitals (monthly 76 & annually). Data from the divisions of Antimicrobial-Resistant Bacterial Infection (ARBI) and Clinical 77 Laboratory (CL) at JANIS were accessed [14] . These data represent 10% and 19.5% of hospitals (2016) 78 respectively [15] . The CL division reports prevalence of bacteria amongst clinical isolates based on 79 microbiological data [14] . Whilst ARBI data have less coverage, they are used here as capture the 80 incidence of seven different (multi)drug-resistant infections associated with six bacteria, including 81 MRSA, amongst hospitalised patients. The ARBI data are more comparable with England data on 82 MRSA BSI rather than the CL data. The CL data are included as supplementary data (Appendix A, 83 infections, harnessing national commitment to patient safety, followed by country actions globally. 93
As a first study to provide a rapid, efficient, but in-depth comparison of approaches post-2000, 94 between Japan and England, a decision to use secondary sources was taken; setting the ground for 95 future interviews and surveys. 96
The sampling was informed by field experts, such as senior clinicians and policy makers in each 97 country. For Japan, a total of 275 textual sources were analysed from four main categories: (a) policy 98 documents, guidelines, and legislation produced by Japan Since 1996, the Japanese government has promoted infection control in hospitals using a medical 159 reimbursement system. Hospitals which have in place methods for developing staff and capacity 160 building as well as taking part in surveillance, establishment of a hospital infection control 161 department/committee, and associated activities, are eligible to apply for an additional fee through 162 reimbursement systems. Those hospitals that do not have systems to monitor optimal use of 163 antimicrobials are barred from applying for this fee. A key feature of monitoring must be either a 164 notification or permission system for broad spectrum antibiotics. 
The speed of success in the reduction of MRSA infections may be explained by these factors and 246 approaches but causation of course cannot be attributed (Table II) Culturally, in Japan, the learning from the quality improvement movement in health and other 270 sectors advocates internal (to the organisation) drivers and motivators [118] . This is seen also in the 271 way that financial incentives (rather than punitive measures) for AMR interventions in Japan have 272 been used (e.g. In view of an increasing use of broad spectrum antimicrobials in Japan, some scholars suggest a 291 restrictive approach to the use of fluoroquinolones [120] . Possible longer-term impacts of restrictive 292 policy intervention on the reduction of MRSA through banning routine use of antibiotics has also 293 been discussed in the UK context [121] . A way forward for Japan may be to further nurture intrinsic 294 motivations and drivers with stable, supportive government combined with personal and 295 professional stewardship [122] and regional governance [123], given the complex involvement of 296 vested interest groups in policy making processes [124] . Addiitonally, if Japan were to shift from 297 confidential to public reporting of MRSA, its unintended consequences should be monitored [125] . 298
The methods of healthcare funding and reimbursement mechanisms can influence antibiotic 299 prescription [126], hence consequently affecting AMR. In Japan, it is possible to induce the 300 implementation of healthcare by revising medical fees every two years. However, such system would 301 require commitment from hospital leads. 302 A higher level of healthcare utilisation and unique demographic shifts with falling birth rates to 303 contribute to healthcare funding for increasing aging population in Japan are also a reminder of 304 challenges which lay ahead. Addressing avoidable costs to healthcare are therefore a priority. 305
From a more sociological perspective, the relationship between national cultural values and 306 behaviour change in relation to IPC and antimicrobial stewardship needs to be investigated in Japan with limitations, and systems where a review process to verify infections and why they have 320 happened provides information for learning. Future research will address local level implementation 321 and perceptions of the interventions presented here through primary data (e.g. interviews with key 322 informants) to triangulate and/or understand local effects. Future work must also understand the 323 profile and trends in the community and across the whole health economy. 324
As an initial analysis, Leichter's four main dimensions of contextual factors are helpful for 325 understanding potential for transferability between countries, but a more detailed analysis of 326 governance approaches would be beneficial [3] . The approach here neglects the reality of complex 327 and dynamic social phenomena but provides a framework for future cross-national comparisions for 328 mutual learning. 329 330
Conclusions 331
In Japan, international drivers seem to have led to increased national commitment, but nationally, 332 the approach is characterised by voluntary surveillance and a more persuasive approach for clinical 333 professionals rather than a mandatory approach for institutional management. England has reached 334 the extremes of mandatory reporting and ever increasing information in the public domain. 6   Table II Comparison of the wider contextual factors and approaches to MRSA reduction / quality improvement between Japan and England (/UK) The medical payment is calculated based on medical fee points. Patients pay part of this amount, and the public health insurance pays the remainder. The revision of the medical fee points is decided by the cabinet, the committee on health insurance, and the central social insurance medical council. These medical fee points are revised every two years.
Beveridge Model. NHS being publicly funded through taxation, and characterised by state regulation and control in the provision of services [112] .
Public system financing [113]
General tax revenue; insurance contributions.
General tax revenue (includes employment-related insurance contributions). [England]
Provider ownershiphospitals [113] Mainly private non-profit (~70% of beds), some public (~30%). Mostly public, some private. [England] Hospital payment [113] Case-based per diem payments and fee-for-service or fee-for-service only (includes physician costs). Nationally-based initiatives ahead of aspects of global initiatives.
Approaches to MRSA reduction / quality improvement

Requirement of surveillance
Voluntary: JANIS voluntary surveillance scheme since 2000 (but more comprehensively since 2007).
Mandatory:
National MRSA mandatory surveillance since 2001. Zero tolerance approach to MRSA bloodstream infections and mandatory Post Infection Review (replacing previous root cause analysis) since April 2013.
Mode of reporting / accountability
Closed information -confidential reporting: Hospital names are anonymised in JANIS open data sources, not intending to promote competitions between hospitals, but to encourage them to improve against their own historical performance trajectories (as bench-marking).
Open information -public reporting: Detailed information disclosure to the public done in an early period (e.g. public reporting of MRSA bloodstream infections at trust level began in 2002).
Mode of motivation
Mainly intrinsic but with long-term objectives based largely on principles of Kaizen (continuous quality improvement).
Both extrinsic & intrinsic.
Examples of incentive / sanction
Financial incentive: Many AMR interventions use financial incentives such as medical reimbursement system.
Process-oriented sanction: Monetary sanctions were held at one time, and the sanctions targeted the infection control measure at hospitals. Process indicators considered as useful in Japan because immediate changes can be implemented.
Financial incentive: Commissioning for Quality and Innovation (CQUIN); quality premium.
Outcomes-oriented sanction: Monetary sanctions were held for hospitals that cannot fulfil target reduction rates.
Abbreviations: AMR, antimicrobial resistance; GDP, Growth Domestic Product; JANIS, Japan Nosocomial Infections Surveillance; MRSA, methicillin-resistant Staphylococcus aureus; NHS, National Health Service. NB: The UK comprises England, Scotland, Wales, and Northern Ireland. The data that are only available for the UK are specified in the table. *1) Power distance: the degree to which the less powerful members of a society accept and expect that power is distributed unequally; 2) Individualism (versus Collectivism): preference for a loosely-knit social framework in which individuals are expected to take care of only themselves and their immediate families; 3) Masculinity (versus Femininity): a preference in society for achievement, heroism, assertiveness, and material rewards for success; 4) Uncertainty avoidance: the degree to which the members of a society feel uncomfortable with uncertainty and ambiguity; 5) Long-term orientation (versus short-term normative orientation): Long-term orientation takes a more pragmatic approach, encouraging thrift and efforts in modern education as a way to prepare for the future; 6) Indulgence (versus Restraint): Indulgence stands for a society that allows relatively free gratification of basic and natural human drives related to enjoying life and having fun. 
Japan (left):
England (right):
